Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial87

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial16

Views

Views
December 20252
January 20262
February 20260
March 20266
April 20263
May 20261
June 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Uruguay2
Colombia1
Spain1
Fiji1
United Kingdom1
Greece1
Mexico1
Paraguay1
Turkey1
 

Top cities views

Views
Athens1
Bogotá1
Chicago1
Coronel Oviedo1
Istanbul1
Montevideo1
Santiago de Compostela1
Seal Beach1
Suva1